Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV kicked out: Fundament for a new therapy established

29.06.2007
A new enzyme eradicates the AIDS-virus from the host-cell genome

A complete cure from an HIV-infection is currently not available. At present, lifelong treatment regimes are required to block the outbreak of AIDS, and these treatments do not eliminate the integrated provirus from infected cells. Now, scientists from the Heinrich-Pette-Institute for Experimental Virology and Immunology (HPI) in Hamburg and the Max-Planck-Institute of Molecular Cell Biology und Genetics in Dresden (MPI-CBG) have developed an enzyme that specifically cuts out the viral genome and eradicates the virus from the host cell. (Science, June, 29th 2007)

HIV introduces its genetic material into the DNA of body cells permanently. In particular, the immune cells are doomed due to the production of new viruses. The teams of Joachim Hauber from the HPI and Frank Buchholz from the MPI-CBG have now succeeded in specifically removing the viral DNA from infected cells. "We got rid of the virus from the infected cells; nobody has done this before", the scientists commented.

To achieve this result they genetically engineered a recombinase, an enzyme that works like molecular scissors. Recombinases cut and paste DNA sequences at specific sites. "Naturally occurring recombinases do not recognize viral sequences and are therefore not useful for an anti-viral approach", said Buchholz: "So we had to develop a recombinase that recognizes the viral sequence and removes the virus with precision."

... more about:
»DNA »HIV »enzyme »eradicate »recombinase »sequence

The molecular biologists started from a recombinase that naturally is found in a bacteriophage. This enzyme, termed "Cre", does not recognize sequences from the HIV genome. Using the forces of evolution the scientists used more than 120 generation cycles to breed the enzyme "Tre", which is now able to recognize HIV sequences.

"Although Tre has so far only been tested in tissue culture cells, this work lays the technical foundation for a novel therapeutic approach that one day might be used to eradicate the HIV from cells of infected patients" said Hauber. However, it is still a long way until this approach can be used in clinical practice. "We will first go back to the bench to further improve the enzyme and then test whether the recombinase can be delivered efficiently and safely to cells in the human body", said Buchholz and Hauber.

Original publication
Indrani Sarkar, Ilona Hauber, Joachim Hauber, Frank Buchholz
HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Science, June, 29th, 2007
Further information can be obtained from:
Dr. Frank Buchholz
Max-Planck-Institut für Molekulare Zellbiologie und Genetik, Dresden
E-Mail: buchholz@mpi-cbg.de
Prof. Dr. Joachim Hauber
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Hamburg
E-Mail: joachim.hauber@hpi.uni-hamburg.de

Dr. Angela Homfeld | idw
Further information:
http://www.hpi-hamburg.de
http://www.max-wissen.de/?find=me&id=5197
http://www.mpi-cbg.de

Further reports about: DNA HIV enzyme eradicate recombinase sequence

More articles from Life Sciences:

nachricht Fingerprint' technique spots frog populations at risk from pollution
27.03.2017 | Lancaster University

nachricht Parallel computation provides deeper insight into brain function
27.03.2017 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>